Fresenius Medical Care AG & Co. KGaA (FME) Stock Statistics & Valuation Metrics

Fresenius Medical Care AG & Co. KGaA has a market cap or net worth of EUR 10.82B. The enterprise value is EUR 21.16B.

Market Cap

EUR 10.82B

Enterprise Value

EUR 21.16B

Fresenius Medical Care AG & Co. KGaA has 268,564,640 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding

268,564,640

Owned by Insiders

―

Owned by Institutions

28.55%

Fresenius Medical Care AG & Co. KGaA’s return on equity (ROE) is 0.07 and return on invested capital (ROIC) is 5.34%.

Return on Equity (ROE)

0.07

Return on Assets (ROA)

0.03

Return on Invested Capital (ROIC)

5.34%

Return on Capital Employed (ROCE)

0.07

Revenue Per Employee

183.05K

Profits Per Employee

9,120.922

Employee Count

107,226

Asset Turnover

0.63

Inventory Turnover

6.82

The current PE Ratio of Fresenius Medical Care AG & Co. KGaA is 13.65. Fresenius Medical Care AG & Co. KGaA’s PEG ratio is 0.63.

PE Ratio

13.65

PS Ratio

0.54

PB Ratio

0.84

Price to FCF

5.90

Price to Operating Cash Flow

3.72

PEG Ratio

0.63

In the last 12 months, Fresenius Medical Care AG & Co. KGaA had revenue of 19.63B and earned 978.00M in profits. Earnings per share was 3.36.

Revenue

19.63B

Gross Profit

5.03B

Operating Income

1.83B

Pretax Income

1.51B

Net Income

978.00M

EBITDA

3.34B

Earnings Per Share (EPS)

3.36

In the last 12 months, operating cash flow was 2.89B and capital expenditures -1.09B, giving a free cash flow of 1.79B billion.

Operating Cash Flow

2.89B

Free Cash Flow

1.79B

Free Cash Flow per Share

6.83

Fresenius Medical Care AG & Co. KGaA pays an annual dividend of EUR 1.49, resulting in a dividend yield of 3.65%

Dividend Per Share

EUR 1.49

Dividend Yield

3.65%

Payout Ratio

34.17%

Free Cash Flow Yield

16.95%

Earnings Yield

7.67%

Beta

0.43

52-Week Price Change

-1.66%

50-Day Moving Average

39.45

200-Day Moving Average

39.16

Relative Strength Index (RSI)

53.21

Average Volume (3m)

881.26K

Fresenius Medical Care AG & Co. KGaA upcoming earnings date is Feb 23, 2027, TBA (Not Confirmed).

Last Earnings Date

Nov 03, 2026

Next Earnings Date

Feb 23, 2027

Ex-Dividend Date

May 22, 2026

Fresenius Medical Care AG & Co. KGaA as a current ratio of 1.26, with Debt / Equity ratio of 81.11%

Current Ratio

1.26

Quick Ratio

0.92

Debt to Market Cap

0.62

Net Debt to EBITDA

2.76

Interest Coverage Ratio

4.74

In the past 12 months, Fresenius Medical Care AG & Co. KGaA has paid 321.00M in taxes.

Income Tax

321.00M

Effective Tax Rate

0.21

Fresenius Medical Care AG & Co. KGaA EV to EBITDA ratio is 5.77, with an EV/FCF ratio of 11.35.

EV to Sales

1.05

EV to EBITDA

5.77

EV to Free Cash Flow

11.35

EV to Operating Cash Flow

7.06

Fresenius Medical Care AG & Co. KGaA has EUR 1.48B in cash and marketable securities with EUR 10.89B in debt, giving a net cash position of -EUR 9.40B billion.

Cash & Marketable Securities

EUR 1.48B

Total Debt

EUR 10.89B

Net Cash

-EUR 9.40B

Net Cash Per Share

-EUR 35.01

Tangible Book Value Per Share

-EUR 5.77

Gross margin is 26.46%, with operating margin of 10.64%, and net profit margin of 4.22%.

Gross Margin

26.46%

Operating Margin

10.64%

Pretax Margin

7.20%

Net Profit Margin

4.22%

EBITDA Margin

18.12%

EBIT Margin

10.30%

The average price target for Fresenius Medical Care AG & Co. KGaA is EUR 36.38, which is 11.43% higher than the current price. The consensus rating is Moderate Sell

Price Target

EUR 36.38

Price Target Upside

10.85% Downside

Analyst Consensus

Moderate Sell

Analyst Count

10

Revenue Growth Forecast

-0.83%

EPS Growth Forecast

22.00%

Smart Score

1

AI Score

69